India's IOL Chemicals jumps over 10% on nod to export product to China
** Shares of IOL Chemicals And Pharma IOLC.NS up as much
as 10.3% at 446.50 rupees
** Co says its product metformin hydrochloride has been
approved by Center for Drug Evaluation of National Medical
Products Administration, China
** IOLC, which makes and sells various active pharma
ingredients, says move will enable co to export metformin
hydrochloride in China Market
** 1.2 mln shares change hands, sees best session since Jan
2
** Stock gained 24% in 2023, down 4.1% YTD
(Reporting by Sethuraman NR in Bengaluru)
((Sethuraman.NR@thomsonreuters.com; (+91 9945291420); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))
Recent news on IOL Chemicals and Pharmaceuticals
See all newsBrief: Iol Chemicals And Pharmaceuticals Says European Directorate For Quality Of Medicines & Healthcare Grants Certificate For Fenofibrate–Process II
Brief: IOL Chemicals And Pharmaceuticals June-Quarter Consol Profit 644 Million Rupees
Brief: IOL Chemicals and Pharmaceuticals Gets Approval From NMPA, China For Clopidogrel Bisulfate API
Brief: IOL Chemicals And Pharmaceuticals Reports Minor Fire Incident In Unit-9B Minoxidil Manufacturing Unit On June 9
Brief: IOL Chemicals And Pharmaceuticals March-Quarter Consol Profit 531.6 Million Rupees